Bayer (BAYRY) Stock Price, Quote, News & History

Q: What sector and industry does Bayer (BAYRY) operate in?

Bayer is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQX.

Bayer AG (BAYRY) Stock Price, Quote, News & History

BAYRYOTCQX

Trade with Public

$13.77

0.362.68%

At close: Feb 6, 4:00 PM EST

Key Statistics

Open

$13.77

Volume / Avg.

0 / 793.21K

Day Range

- - -

52 Wk Range

5.30 - 13.98

Market Cap

$54.11B

P/E Ratio

Dividend Yield

0.23%

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Bayer AG News

Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

Bayer's asundexian cut ischemic stroke risk without more bleeding, boosting FXIa optimism while raising fresh questions for Bristol Myers' milvexian program.

Vandana Singh

FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising

FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.

Vandana Singh

Siemens Warns Currency Headwinds Will Hit 2026 Results; CEO Defends Mid-Term Target

European Capital Insights

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

6.73B

Investing Cash Flow (TTM)

-2.05B

Financing Cash Flow (TTM)

-3.10B

Free Cash Flow (TTM)

3.94B

Capital Expenditure (TTM)

-2.79B

Net Change in Cash (TTM)

1.58B

Valuation Metrics

Enterprise Value

$91.39B

PE Ratio (TTM)

PE Ratio (FWD)

8.91

PEG Ratio (TTM)

PS Ratio (TTM)

1.00

PB Ratio (TTM)

1.55

Earnings Yield % (TTM)

-0.43%

Earnings Yield % (FWD)

11.22%

EV / EBITDA (TTM)

12.58

Price / EBITDA (TTM)

7.38

Price / Free Cash Flow (TTM)

11.62

Book Value / Share

$8.90

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

$7.15B

LT Debt Repayment (TTM)

-$8.33B

Total Cash

$5.90B

Debt to Equity

Issuance of Debt (TTM)

-$1.19B

Repayment of Debt (TTM)

-$8.33B

Key Statistics

Open

$13.77

Volume / Avg.

0 / 793.21K

Day Range

- - -

52 Wk Range

5.30 - 13.98

Market Cap

$54.11B

P/E Ratio

Dividend Yield

0.23%

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm's crop science business sells s...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Bayer (BAYRY) stock?

You can purchase shares of Bayer (OTCQX:BAYRY) through any online brokerage.

View our list of the best stock brokerages

Who are Bayer (BAYRY) competitors?

There are no as such competitors for Bayer.

What is the forecast, or price target, for Bayer (BAYRY) stock?

There is no analysis for Bayer to provide a consensus price target.

What is the current price for Bayer (BAYRY)?

The stock price for Bayer (OTCQX: BAYRY) is $13.77 last updated February 9, 2026 at 3:59 PM EST.

Does Bayer (BAYRY) pay a dividend?

There are no upcoming dividends for Bayer.

When is Bayer (OTCQX:BAYRY) reporting earnings?

Bayer does not have any upcoming earnings scheduled.

Is Bayer (BAYRY) going to split?

There is no upcoming split for Bayer.

What sector and industry does Bayer (BAYRY) operate in?

Bayer is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQX.

Key Statistics

Open

$13.77

Volume / Avg.

0 / 793.21K

Day Range

- - -

52 Wk Range

5.30 - 13.98

Market Cap

$54.11B

P/E Ratio

Dividend Yield

0.23%

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Bayer AG News

Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

Bayer's asundexian cut ischemic stroke risk without more bleeding, boosting FXIa optimism while raising fresh questions for Bristol Myers' milvexian program.

Vandana Singh

FDA Signs Off On Bayer's New Lung Cancer Drug — Early Results Look Promising

FDA grants accelerated approval to Bayer's Hyrnuo and full approval to Amgen's Imdelltra, expanding treatment options for advanced lung cancer.

Vandana Singh

Siemens Warns Currency Headwinds Will Hit 2026 Results; CEO Defends Mid-Term Target

European Capital Insights